Vilà-Quintana Laura, Fort Esther, Pardo Laura, Albiol-Quer Maria T, Ortiz Maria Rosa, Capdevila Montserrat, Feliu Anna, Bahí Anna, Llirós Marc, Aguilar Esther, García-Velasco Adelaida, Ginestà Mireia M, Laquente Berta, Pozas Débora, Lluansí Aleix, Pimenoff Ville Nikolai, Moreno Victor, Garcia-Gil Libadro Jesús, Duell Eric J, Carreras-Torres Robert, Aldeguer Xavier
Digestive Diseases and Microbiota Group, Department of Gastroenterology, Girona Biomedical Research Institute (IDIBGI), Hospital Universitari de Girona Dr. Josep Trueta, 17190 Salt, Spain.
General and Digestive Surgery Group, Department of Surgery, Girona Biomedical Research Institute (IDIBGI), Hospital Universitari de Girona Dr. Josep Trueta, 17007 Girona, Spain.
J Clin Med. 2024 Apr 12;13(8):2247. doi: 10.3390/jcm13082247.
Identifying biomarkers linked to pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP) is crucial for early detection, treatment, and prevention. Association analyses of 10 serological biomarkers involved in cell signalling (IFN-γ, IL-6, IL-8, IL-10), oxidative stress (superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzyme activities, total glutathione (GSH), malondialdehyde (MDA) levels), and intestinal permeability proteins (zonulin, I-FABP2) were conducted across PDAC ( = 12), CP ( = 21) and control subjects ( = 23). A Mendelian randomisation (MR) approach was used to assess causality of the identified significant associations in two large genetic cohorts (FinnGen and UK Biobank). Observational results showed a downregulation of SOD and GPx antioxidant enzyme activities in PDAC and CP patients, respectively, and higher MDA levels in CP patients. Logistic regression models revealed significant associations between CP and SOD activity (OR = 0.21, 95% CI [0.05, 0.89], per SD), GPx activity (OR = 0.28, 95% CI [0.10, 0.79], per SD), and MDA levels (OR = 2.05, 95% CI [1.36, 3.08], per SD). MR analyses, however, did not support causality. These findings would not support oxidative stress-related biomarkers as potential targets for pancreatic diseases prevention. Yet, further research is encouraged to assess their viability as non-invasive tools for early diagnosis, particularly in pre-diagnostic CP populations.
识别与胰腺导管腺癌(PDAC)和慢性胰腺炎(CP)相关的生物标志物对于早期检测、治疗和预防至关重要。对参与细胞信号传导(IFN-γ、IL-6、IL-8、IL-10)、氧化应激(超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)酶活性、总谷胱甘肽(GSH)、丙二醛(MDA)水平)以及肠道通透性蛋白(闭合蛋白、I-FABP2)的10种血清生物标志物进行了关联分析,涉及PDAC患者(n = 12)、CP患者(n = 21)和对照受试者(n = 23)。采用孟德尔随机化(MR)方法在两个大型遗传队列(芬兰基因队列和英国生物银行)中评估已确定的显著关联的因果关系。观察结果显示,PDAC和CP患者的SOD和GPx抗氧化酶活性分别下调,CP患者的MDA水平更高。逻辑回归模型显示CP与SOD活性(OR = 0.21,95%CI [0.05, 0.89],每标准差)、GPx活性(OR = 0.28,95%CI [0.10, 0.79],每标准差)和MDA水平(OR = 2.05,95%CI [1.36, 3.08],每标准差)之间存在显著关联。然而,MR分析不支持因果关系。这些发现不支持将氧化应激相关生物标志物作为预防胰腺疾病的潜在靶点。然而,鼓励进一步研究评估它们作为早期诊断的非侵入性工具的可行性,特别是在诊断前的CP人群中。
Diabetes Metab Res Rev. 2019-3-25
World J Gastroenterol. 2021-7-14
Am J Physiol Gastrointest Liver Physiol. 2021-7-1
Int J Cancer. 2021-4-15
United European Gastroenterol J. 2020-10
Redox Biol. 2020-4
World J Oncol. 2019-2